Elizabeth Holmes, founder of fraudulent blood-testing startup Theranos, will be transferred from federal prison to a halfway home in Austin, Texas in August 2024, with her full release scheduled for February 2030. She was sentenced to over 11 years in 2022 for defrauding investors of hundreds of millions of dollars through false claims about the company's disease-detection technology.
Elizabeth Holmes, founder of failed blood-testing startup Theranos, will be transferred from federal prison to a halfway home in Austin, Texas next August as part of her 11-year sentence for defrauding investors. Holmes was convicted in 2022 for falsely promoting Theranos technology as capable of detecting diseases from finger-prick blood samples and is scheduled for release in February 2030.